NanoViricides
NNVC
#10122
Rank
NZ$39.17 M
Marketcap
NZ$2.18
Share price
0.00%
Change (1 day)
-15.11%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): NZ-$1.12

According to NanoViricides's latest financial reports the company's current EPS (TTM) is NZ-$1.16. In 2024 the company made an earnings per share (EPS) of NZ-$1.21 an increase over its 2023 EPS that were of NZ-$1.28.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$1.12-6.99%
2024NZ-$1.21-5.41%
2023NZ-$1.285.71%
2022NZ-$1.21-13.58%
2021NZ-$1.40-66.11%
2020NZ-$4.131.7%
2019NZ-$4.06-10.98%
2018NZ-$4.56-22.35%
2017NZ-$5.87-10.53%
2016NZ-$6.57375%
2015NZ-$1.38-85.19%
2014NZ-$9.3342.11%
2013NZ-$6.5726.67%
2012NZ-$5.18-6.25%
2011NZ-$5.5314.28%
2010NZ-$4.84100%
2009NZ-$2.42-0%
2008NZ-$2.42-33.33%
2007NZ-$3.63-0%
2006NZ-$3.634445.07%
2005NZ-$0.07983

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioCryst Pharmaceuticals
BCRX
NZ-$0.08639-92.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$3.66-416.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.27-1,073.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.13-543.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.12-1,233.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.21-636.71%๐Ÿ‡ฌ๐Ÿ‡ง UK